Advanced search
1 file | 228.82 KB Add to list

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

(2017) BREAST. 37. p.52-55
Author
Organization
Keywords
Immunohistochemistry, Genomic testing, Breast cancer, HER2, Hormone receptor status, RT-qPCR, RNA, CARCINOMA IN-SITU, AMERICAN PATHOLOGISTS GUIDELINE, INTERNATIONAL EXPERT CONSENSUS, ONCOTYPE DX TEST, CLINICAL ONCOLOGY/COLLEGE, ESTROGEN-RECEPTOR, RECURRENCE RISK, PRIMARY THERAPY, HER2, EXPRESSION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 228.82 KB

Citation

Please use this url to cite or link to this publication:

MLA
Van Bockstal, Mieke, Giuseppe Floris, Christine Galant, et al. “A Plea for Appraisal and Appreciation of Immunohistochemistry in the Assessment of Prognostic and Predictive Markers in Invasive Breast Cancer.” BREAST 37 (2017): 52–55. Print.
APA
Van Bockstal, M., Floris, G., Galant, C., Lambein, K., & Libbrecht, L. (2017). A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer. BREAST, 37, 52–55.
Chicago author-date
Van Bockstal, Mieke, Giuseppe Floris, Christine Galant, Kathleen Lambein, and Louis Libbrecht. 2017. “A Plea for Appraisal and Appreciation of Immunohistochemistry in the Assessment of Prognostic and Predictive Markers in Invasive Breast Cancer.” Breast 37: 52–55.
Chicago author-date (all authors)
Van Bockstal, Mieke, Giuseppe Floris, Christine Galant, Kathleen Lambein, and Louis Libbrecht. 2017. “A Plea for Appraisal and Appreciation of Immunohistochemistry in the Assessment of Prognostic and Predictive Markers in Invasive Breast Cancer.” Breast 37: 52–55.
Vancouver
1.
Van Bockstal M, Floris G, Galant C, Lambein K, Libbrecht L. A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer. BREAST. 2017;37:52–5.
IEEE
[1]
M. Van Bockstal, G. Floris, C. Galant, K. Lambein, and L. Libbrecht, “A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer,” BREAST, vol. 37, pp. 52–55, 2017.
@article{8551973,
  author       = {Van Bockstal, Mieke and Floris, Giuseppe and Galant, Christine and Lambein, Kathleen and Libbrecht, Louis},
  issn         = {0960-9776},
  journal      = {BREAST},
  keywords     = {Immunohistochemistry,Genomic testing,Breast cancer,HER2,Hormone receptor status,RT-qPCR,RNA,CARCINOMA IN-SITU,AMERICAN PATHOLOGISTS GUIDELINE,INTERNATIONAL EXPERT CONSENSUS,ONCOTYPE DX TEST,CLINICAL ONCOLOGY/COLLEGE,ESTROGEN-RECEPTOR,RECURRENCE RISK,PRIMARY THERAPY,HER2,EXPRESSION},
  language     = {eng},
  pages        = {52--55},
  title        = {A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer},
  url          = {http://dx.doi.org/10.1016/j.breast.2017.10.012},
  volume       = {37},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: